The IvyGene Breast Test will be available in 2019. The IvyGene Breast technology was presented at the San Antonio Breast Cancer Symposium in January 2019. The Breast Test will provide patients with abnormal mammograms or inconclusive results a highly accurate way to confirm the presence of breast cancer.
The IvyGene technology analyzes methylation ratios at specific gene targets in cell-free DNA. By identifying which gene targets are consistently hyper-methylated when cancer is present, the IvyGene technology is a highly accurate way to confirm the presence of cancer
Only a medical provider may order the test. The test is performed through a simple blood draw [40mls]. Shipping is included in the wholesale price of the test. Results are returned within 5 business days.